Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
NCT06549595
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Research Site Huntsville, Alabama, United States
- Research Site Anchorage, Alaska, United States
- Research Site Phoenix, Arizona, United States
- Research Site Clovis, California, United States